Xi Chen Lin
Direttore Tecnico/Scientifico/R&S presso STRUCTURE THERAPEUTICS INC.
Patrimonio netto: 976 962 $ in data 31/05/2024
Profilo
Xi Chen Lin is currently the Chief Scientific Officer at Structure Therapeutics, Inc. and also holds a position as General Manager at Shanghai ShouTi Biotechnology Co. Ltd.
Prior to these roles, Dr. Lin worked as the Head-Asia Pacific External Innovation at Novo Nordisk A from 2016 to 2019.
Dr. Lin received an undergraduate degree from Peking University and a doctorate degree from The Pennsylvania State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 03/06/2024 | 85 707 ( 0.06% ) | 976 962 $ | 31/05/2024 |
Posizioni attive di Xi Chen Lin
| Società | Posizione | Inizio |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2019 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Amministratore Delegato | - |
Precedenti posizioni note di Xi Chen Lin
| Società | Posizione | Fine |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/07/2019 |
Formazione di Xi Chen Lin
| Peking University | Undergraduate Degree |
| The Pennsylvania State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| NOVO NORDISK A/S | Health Technology |
| Aziende private | 1 |
|---|---|
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Health Technology |
- Borsa valori
- Insiders
- Xi Chen Lin
